ACE and COVID-19: Second, our analysis did not adjust for the potential impact of treatments like corticosteroids, ACE inhibitors, statins, or vaccines on cardiovascular outcomes post-discharge, which may significantly confound the observed association between severe COVID-19 and increased cardiovascular risk.